MOUNTAINSIDE, NJ--(Marketwire - January 25, 2010) -
| Highlighted Links |
|
|
Proteonomix, Inc. (PINKSHEETS: PROT) reports on the recent online articles about its operations published by www.immortalhumans.com and www.associatedcontent.com.
The website of Immortalhumans.com states, “A firm called National Stem Cell was the initial business to utilize a human enzyme from an embryonic source in a skin care product line. However, they are changing to enzymes from non-stem cells. They are switching their name to Proteonomix.”
The website of Associatedcontent.com states, “National Stem Cell was the first company to use an enzyme from human embryonic stem cells in their skin care line, but they’re switching to enzymes from non-stem cells. They are also changing their name to Proteonomix. They advertise that their products will ‘enhance the formation of natural collagen’ and ‘make skin appear smoother and firmer’.”
ReVive, Amatokin and Swiss Apple Stem Cell products have been used as comparables in these articles.
The articles are correct in that Proteonomix and its subsidiary, Proteoderm, Inc., were the first to discover and produce anti-aging products based on the stem cell derivatives. However, the following inaccuracies were incorporated in the articles:
Nation Stem Cell, Inc. is a subsidiary of National Stem Cell Holding, Inc. which changed its corporate name to Proteonomix, Inc. in August 2008 in order to reflect the company’s core science and corporate competence. Proteoderm does not utilize embryonic stem cells as a source for its anti-aging skin care products. Proteoderm is the only company to use a matrix of proteins originally derived from non-embryonic stem cells (Matrix NC-138) in its products in order to harness the anti-aging potential of stem cells in a powerful anti-aging skin care cosmeceutical that makes a measurable difference. Proteoderm does not use enzymes, collagen or growth factors which are the ingredients of other anti-aging cosmeceuticals.
Proteoderm has developed an anti-aging kit consisting of a day cream, night cream, cleanser, exfoliant and under eye serum under the brand name “Matrix NC-138" and has entered into an agreement with two China-based companies, for the licensing, sale, and distribution of its cosmeceutical kit in China, Hong Kong and Taiwan, the details of which may be found on Proteonomix’ most recent SEC filing of its registration statement on Form 10.
About Proteonomix, Inc.
Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteonomix has facilities at a number of academic institutions. Its subsidiary, Proteoderm has developed a line of anti-aging cosmetics. Please visit www.proteonomix.com, www.proteoderm.com, www.pinksheets.com and www.sec.gov.
Certain statements contained herein are “forward-looking” statements (as defined -- Private Securities Litigation Reform Act 1995). PROT cautions that the statements made in this press release constitute forward-looking statements and makes no guarantees of future performance and actual results or developments may differ materially from projections in forward-looking statements. Forward-looking statements are based on estimates and opinions of management at time statements are made.
Contact:
Michael Cohen
Proteonomix, Inc.
(973) 544-6116
Digg this
Bookmark with del.icio.us
Add to Newsvine
Technorati: 
